NL-OMON44449已完成不适用
First attempt success ratio of intravenous cannulation with the Veinplicity® - Veinplicity
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 125
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a patient must meet all of the following criteria:
- •* Patients must be in the age of 18 years or older;
- •* Patients with a medium risk profile on the A-DIVA scale (score 2 or 3);
- •* Patients must be conscious and be able to adequately answer questions.
排除标准
- •A potential patient who meets any of the following criteria will be excluded from participation in this study:
- •* Patients in which an intravenous catheter is already inserted on the ward;
- •* Patients with medical devices in the body (pacemaker, ICD, trans-cerebral electrode placement, electrode placement that applies current to the carotid sinus region, other neurostimulators);
- •* Patients who do not understand questions or generate adequate data, due to physical or communicational disorders.
研究者
相似试验
尚未招募
不适用
First attempt success ratio of intravenous cannulation with the Veinplicity®Difficult intravenous access, unsuccessful attempt to insert a peripheral intravenous catheter.NL-OMON24775Catharina HospitalDepartment of anesthesiology, intensive care and pain medicineMichelangelolaan 25623 EJ Eindhoven125
尚未招募
不适用
comparison of ultrasound guided needle insertion success vs landmark guided in percutaneous tracheostomyCTRI/2021/02/031580Sangeeta Chakraborty
尚未招募
1 期
Mesenchymal Stem Cell Therapy For Covid 19CTRI/2020/08/027043eurogen Brain and Spine Institute
招募中
1 期
A Phase-I clinical study of intravenous AntiPlatelet, AntiCoagulant (APAC) in healthy subjects.CTRI/2023/04/051500Cadila Pharmaceutical Limited
已完成
不适用
Phase1 clinical study of a single intravenous dose of TRM-1106 in healthy Japanese adult meJPRN-UMIN000005914Terumo Corporation30